Document is current
Any future updates will be listed below
-
Authors
Lebreton, Francois
Kondratiuk, Viacheslav
Kovalchuk, Valentyn
Pfennigwerth, Niels
Luo, Ting L.
Jones, Brendan T.
Fomina, Nadiia
Fuchs, Frieder
Hans, Jörg B.
Eisfeld, Jessica
Ong, Ana
Gatermann, Sören
Bennett, Jason W.
Mc Gann, Patrick
-
Funding
Funding for this research was provided by:
Defense Health Program (DHP) Operation & Maintenance
Ukrainian Ministry of Health (0117U00690, 0117U00690, 0117U00690)
German Ministry of Health (1369-402, 1369-402, 1369-402, 1369-402)
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 20 June 2025
First Online: 1 July 2025
Declarations
:
: The isolates and clinical information were collected as part of the public health surveillance activities of the MRSN, as determined by the WRAIR Commander in accordance with Institutional Review Board (IRB) Policy Memorandum #10; Public Health activity Determination and Oversight Requirements issued June 10th 2019. For Ukrainian samples, hospital permission to conduct the surveillance study was obtained from Hospital Bioethics Committee of MMCC CR, Ministry of Defense, Vinnitsa, Ukraine, protocol reference number 18/2 from 05 May 2014. The patients were included after understanding the study and had signed an informed consent. The research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.
